KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 0.29.

  • Jazz Pharmaceuticals' Asset Utilization Ratio fell 1352.97% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year decrease of 1352.97%. This contributed to the annual value of 0.35 for FY2024, which is 78.58% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Asset Utilization Ratio of 0.29 as of Q3 2025, which was down 1352.97% from 0.28 recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.37 in Q1 2021 and a low of 0.22 during Q3 2021
  • Over the past 5 years, Jazz Pharmaceuticals' median Asset Utilization Ratio value was 0.34 (recorded in 2024), while the average stood at 0.31.
  • In the last 5 years, Jazz Pharmaceuticals' Asset Utilization Ratio crashed by 3958.97% in 2021 and then skyrocketed by 4899.66% in 2022.
  • Quarter analysis of 5 years shows Jazz Pharmaceuticals' Asset Utilization Ratio stood at 0.25 in 2021, then soared by 38.09% to 0.34 in 2022, then fell by 1.61% to 0.34 in 2023, then dropped by 1.18% to 0.34 in 2024, then decreased by 12.81% to 0.29 in 2025.
  • Its last three reported values are 0.29 in Q3 2025, 0.28 for Q2 2025, and 0.27 during Q1 2025.